Adamis Pharmaceuticals | ADMP - Market Capitalization


Adamis Pharmaceuticals reported $700K in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Cara Therapeutics USD 366M 338M Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
RedHill Biopharma USD 12M 17M Jun/2024